4,5,6,7-Tetrahydro-[1,2,3]triazolo[1,5-a]pyrazine, 95.0%, 100mg

3-N-Boc-Amino-5-bromothiophene, 95.0%, 100g

2-Cyano-2-phenylacetamide, 95.0%, 1g

2-(2-Fluoro-[1,1'-biphenyl]-4-yl)acetic acid, 95.0%, 250mg

tert-Butyl 4-(hydroxyimino)piperidine-1-carboxylate, 95.0%, 100g

4-(4-Aminophenyl)-1-methylpiperidine, 97.0%, 25g

(4S,4'S)-2,2'-(1,3-Bis(4-(tert-butyl)phenyl)propane-2,2-diyl)bis(4-methyl-4,5-dihydrooxazole), 97%, 100mg

Etilenglicol, min 99%, para síntesis, 25 l, envase plástico.

3-Ethoxy-thiophene-2-carboxylic acid methyl ester, 95.0%, 1g

2-Acetamido-5-nitropyridine>98.0%(GC)5g

N-(1-adamantylmethyl)-N-methylamine hydrochloride, 95.0%, 1g

3-(2-Iodoethoxy)prop-1-yne, 98%, 5g

Bis[2,6-difluoro-3-(1H-pyrrol-1-yl)phenyl]titanocene>98.0%(HPLC)5g